Christopher Accettella - Net Worth and Insider Trading
Christopher Accettella Net Worth
The estimated net worth of Christopher Accettella is at least $39,658 dollars as of 2023-09-21. Christopher Accettella is the Portfolio Manager of BlackRock Health Sciences Trust II and owns about 2,635 shares of BlackRock Health Sciences Trust II (BMEZ) stock worth over $37,786. Christopher Accettella is also the Portfolio Manager of BlackRock Resources & Commodities Strategy Trust and owns about 200 shares of BlackRock Resources & Commodities Strategy Trust (BCX) stock worth over $1,872. Details can be seen in Christopher Accettella's Latest Holdings Summary section.
Transaction Summary of Christopher Accettella
Christopher Accettella Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Accettella owns 12 companies in total, including Blackrock Enhanced Cap&Inc Fund, Inc (CII) , BlackRock Energy & Resources Trust (BGR) , and Blackrock Health Sciences Trust (BME) among others .
Click here to see the complete history of Christopher Accettella’s form 4 insider trades.
Insider Ownership Summary of Christopher Accettella
Christopher Accettella Latest Holdings Summary
Christopher Accettella currently owns a total of 2 stocks. Among these stocks, Christopher Accettella owns 2,635 shares of BlackRock Health Sciences Trust II (BMEZ) as of March 17, 2023, with a value of $37,786 and a weighting of 95.28%. Christopher Accettella also owns 200 shares of BlackRock Resources & Commodities Strategy Trust (BCX) as of August 4, 2011, with a value of $1,872 and a weighting of 4.72%.
Latest Holdings of Christopher Accettella
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BMEZ | BlackRock Health Sciences Trust II | 2023-03-17 | 2,635 | 14.34 | 37,786 |
BCX | BlackRock Resources & Commodities Strategy Trust | 2011-08-04 | 200 | 9.36 | 1,872 |
Holding Weightings of Christopher Accettella
Christopher Accettella Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Accettella has made a total of 3 transactions in BlackRock Health Sciences Trust II (BMEZ) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in BlackRock Health Sciences Trust II is the acquisition of 333 shares on March 17, 2023, which cost Christopher Accettella around $5,078.
According to the SEC Form 4 filings, Christopher Accettella has made a total of 0 transactions in BlackRock Resources & Commodities Strategy Trust (BCX) over the past 5 years. The most-recent trade in BlackRock Resources & Commodities Strategy Trust is the acquisition of 100 shares on August 4, 2011, which cost Christopher Accettella around $1,675.
Insider Trading History of Christopher Accettella
- 1
Christopher Accettella Trading Performance
GuruFocus tracks the stock performance after each of Christopher Accettella's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Accettella is -2.7%. GuruFocus also compares Christopher Accettella's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Accettella within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Accettella's insider trading performs compared to the benchmark.
Performance of Christopher Accettella
Average Relative Return
Outperforming Transactions
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | 0.8 | -2.7 | -10.14 | -21.89 | ||
Relative Return to S&P 500(%) | -0.87 | -7.93 | -15.99 | -13.8 |
Christopher Accettella Ownership Network
Ownership Network List of Christopher Accettella
Ownership Network Relation of Christopher Accettella
Christopher Accettella Owned Company Details

What does Blackrock Enhanced Cap&Inc Fund, Inc do?
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its objective is to provide total return through a combination of current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its total assets in a portfolio of equity securities of U.S. and foreign issuers.
Who are the key executives at Blackrock Enhanced Cap&Inc Fund, Inc?
Christopher Accettella is the other: Portfolio Manager of Blackrock Enhanced Cap&Inc Fund, Inc. Other key executives at Blackrock Enhanced Cap&Inc Fund, Inc include Chief Compliance Officer Aaron David Wasserman , Chief Financial Officer Trent Walker , and other: Portfolio Manager Joseph Wolfe .
Blackrock Enhanced Cap&Inc Fund, Inc (CII) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Blackrock Enhanced Cap&Inc Fund, Inc (CII) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Blackrock Enhanced Cap&Inc Fund, Inc (CII) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Blackrock Enhanced Cap&Inc Fund, Inc (CII)'s detailed insider trading history can be found in Insider Trading Tracker table.
Blackrock Enhanced Cap&Inc Fund, Inc Insider Transactions
Christopher Accettella Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Accettella. You might contact Christopher Accettella via mailing address: 100 Bellevue Parkway, Wilmington De 19809.